Compare JHX & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JHX | BAX |
|---|---|---|
| Founded | 1888 | 1931 |
| Country | Ireland | United States |
| Employees | 5860 | N/A |
| Industry | Building Materials | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | JHX | BAX |
|---|---|---|
| Price | $20.69 | $16.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $27.83 | $21.00 |
| AVG Volume (30 Days) | ★ 6.5M | 6.3M |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $26.06 | $1.96 |
| Revenue Next Year | $14.50 | $2.22 |
| P/E Ratio | $122.05 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $16.46 | $15.73 |
| 52 Week High | $29.83 | $32.68 |
| Indicator | JHX | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 40.92 |
| Support Level | $19.23 | $15.73 |
| Resistance Level | $20.95 | $18.97 |
| Average True Range (ATR) | 0.85 | 0.64 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 27.02 | 4.83 |
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.